Medicine Price Cuts Planned

BMI is maintaining its forecast for South Korea's US$10.5bn pharmaceutical market despite changes to the medicine pricing and purchasing regime. The government is planning to reduce maximum drug prices by 15-25% and intends to punish pharmaceutical companies that offer kickbacks to doctors, hospitals and pharmacies.

To read the full article, please choose one of the following options: